Short-latency afferent inhibition and somato-sensory evoked potentials during the migraine cycle: surrogate markers of a cycling cholinergic thalamo-cortical drive?
Adolescent
Adult
Evoked Potentials, Motor
/ physiology
Evoked Potentials, Somatosensory
/ physiology
Female
Humans
Male
Median Nerve
/ physiopathology
Migraine Disorders
/ physiopathology
Motor Cortex
/ physiopathology
Neural Inhibition
/ physiology
Thalamus
/ physiopathology
Transcranial Magnetic Stimulation
Young Adult
Episodic migraine without aura
GABA
Motor cortex inhibition
Sensorimotor integration
Thalamo-cortical activation
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
16 Apr 2020
16 Apr 2020
Historique:
received:
29
02
2020
accepted:
07
04
2020
entrez:
18
4
2020
pubmed:
18
4
2020
medline:
25
8
2020
Statut:
epublish
Résumé
Short-latency afferent inhibition (SAI) consists of motor cortex inhibition induced by sensory afferents and depends on the excitatory effect of cholinergic thalamocortical projections on inhibitory GABAergic cortical networks. Given the electrophysiological evidence for thalamo-cortical dysrhythmia in migraine, we studied SAI in migraineurs during and between attacks and searched for correlations with somatosensory habituation, thalamocortical activation, and clinical features. SAI was obtained by conditioning the transcranial magnetic stimulation-induced motor evoked potential (MEP) with an electric stimulus on the median nerve at the wrist with random stimulus intervals corresponding to the latency of individual somatosensory evoked potentials (SSEP) N20 plus 2, 4, 6, or 8 ms. We recruited 30 migraine without aura patients, 16 between (MO), 14 during an attack (MI), and 16 healthy volunteers (HV). We calculated the slope of the linear regression between the unconditioned MEP amplitude and the 4-conditioned MEPs as a measure of SAI. We also measured SSEP amplitude habituation, and high-frequency oscillations (HFO) as an index of thalamo-cortical activation. Compared to HV, SAI, SSEP habituation and early SSEP HFOs were significantly reduced in MO patients between attacks, but enhanced during an attack. There was a positive correlation between degree of SAI and amplitude of early HFOs in HV, but not in MO or MI. The migraine cycle-dependent variations of SAI and SSEP HFOs are further evidence that facilitatory thalamocortical activation (of GABAergic networks in the motor cortex for SAI), likely to be cholinergic, is reduced in migraine between attacks, but increased ictally.
Sections du résumé
BACKGROUND
BACKGROUND
Short-latency afferent inhibition (SAI) consists of motor cortex inhibition induced by sensory afferents and depends on the excitatory effect of cholinergic thalamocortical projections on inhibitory GABAergic cortical networks. Given the electrophysiological evidence for thalamo-cortical dysrhythmia in migraine, we studied SAI in migraineurs during and between attacks and searched for correlations with somatosensory habituation, thalamocortical activation, and clinical features.
METHODS
METHODS
SAI was obtained by conditioning the transcranial magnetic stimulation-induced motor evoked potential (MEP) with an electric stimulus on the median nerve at the wrist with random stimulus intervals corresponding to the latency of individual somatosensory evoked potentials (SSEP) N20 plus 2, 4, 6, or 8 ms. We recruited 30 migraine without aura patients, 16 between (MO), 14 during an attack (MI), and 16 healthy volunteers (HV). We calculated the slope of the linear regression between the unconditioned MEP amplitude and the 4-conditioned MEPs as a measure of SAI. We also measured SSEP amplitude habituation, and high-frequency oscillations (HFO) as an index of thalamo-cortical activation.
RESULTS
RESULTS
Compared to HV, SAI, SSEP habituation and early SSEP HFOs were significantly reduced in MO patients between attacks, but enhanced during an attack. There was a positive correlation between degree of SAI and amplitude of early HFOs in HV, but not in MO or MI.
CONCLUSIONS
CONCLUSIONS
The migraine cycle-dependent variations of SAI and SSEP HFOs are further evidence that facilitatory thalamocortical activation (of GABAergic networks in the motor cortex for SAI), likely to be cholinergic, is reduced in migraine between attacks, but increased ictally.
Identifiants
pubmed: 32299338
doi: 10.1186/s10194-020-01104-7
pii: 10.1186/s10194-020-01104-7
pmc: PMC7164277
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
34Références
Clin Neurophysiol. 2008 Feb;119(2):351-5
pubmed: 18065265
Pain. 2014 Jun;155(6):1070-8
pubmed: 24631596
Clin Neurophysiol. 2007 Oct;118(10):2207-14
pubmed: 17709293
Electroencephalogr Clin Neurophysiol. 1996 Jan;100(1):62-7
pubmed: 8964265
Neuroreport. 2015 Aug 5;26(11):634-7
pubmed: 26103117
Headache. 2000 Sep;40(8):657-61
pubmed: 10971662
Front Neurol. 2018 Jan 30;9:25
pubmed: 29441041
Cephalalgia. 2015 Jul;35(8):662-74
pubmed: 25324500
Exp Brain Res. 2000 Dec;135(4):455-61
pubmed: 11156309
J Headache Pain. 2019 Jul 9;20(1):77
pubmed: 31288756
Headache. 2019 Jun;59(6):906-914
pubmed: 31106418
Front Aging Neurosci. 2013 Feb 19;5:2
pubmed: 23423358
J Clin Neurophysiol. 2000 Jul;17(4):377-96
pubmed: 11012041
Headache. 2001 Apr;41(4):377-84
pubmed: 11318884
Brain Stimul. 2011 Oct;4(4):202-9
pubmed: 22032735
Clin Neurophysiol. 2005 Nov;116(11):2592-8
pubmed: 16221561
Cephalalgia. 2011 Oct;31(14):1419-27
pubmed: 21816773
J Neural Transm (Vienna). 2010 Mar;117(3):385-91
pubmed: 19960210
eNeuro. 2014 Dec 30;1(1):e20.14
pubmed: 25893216
eNeuro. 2017 Jan 17;3(6):
pubmed: 28101529
Funct Neurol. 2004 Apr-Jun;19(2):101-5
pubmed: 15274516
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1064-9
pubmed: 16024879
J Neural Transm (Vienna). 2012 Apr;119(4):463-71
pubmed: 22016008
Brain. 2005 Jan;128(Pt 1):98-103
pubmed: 15563513
Exp Brain Res. 2005 Feb;161(1):34-8
pubmed: 15480599
Cephalalgia. 2017 Sep;37(10):915-926
pubmed: 27358281
Parkinsonism Relat Disord. 2014 Jun;20(6):632-6
pubmed: 24698055
J Headache Pain. 2017 Dec;18(1):2
pubmed: 28063106
Pain. 2013 Sep;154(9):1738-42
pubmed: 23693159
Cephalalgia. 2012 Jan;32(1):39-54
pubmed: 22174355
Cephalalgia. 2016 May;36(6):568-78
pubmed: 26442930
Brain Stimul. 2018 Jan - Feb;11(1):59-74
pubmed: 28964754
Cephalalgia. 2012 Jul;32(9):700-9
pubmed: 22652384
Hum Brain Mapp. 2009 Feb;30(2):660-74
pubmed: 18266219
BMC Neurol. 2010 Dec 30;10:126
pubmed: 21192822
Pain Pract. 2015 Apr;15(4):319-22
pubmed: 24725507
J Neural Transm (Vienna). 2013 Mar;120(3):413-22
pubmed: 22903350
Brain Stimul. 2013 Jul;6(4):590-7
pubmed: 23403267
J Physiol. 2005 Nov 15;569(Pt 1):315-23
pubmed: 16141274
Exp Brain Res. 2009 Nov;199(2):177-83
pubmed: 19730839
J Headache Pain. 2018 Aug 9;19(1):65
pubmed: 30094517
Cephalalgia. 2017 Nov;37(13):1241-1247
pubmed: 27815488
Clin Neurol Neurosurg. 2012 Sep;114(7):976-80
pubmed: 22482870
Pain. 2005 Nov;118(1-2):137-44
pubmed: 16213092
J Headache Pain. 2013 Sep 09;14:76
pubmed: 24016158